Inspire Advisors’s Idexx Laboratories IDXX Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q1
$1.34M Buy
2,387
+267
+13% +$171K 0.11% 147
2025
Q4
$1.43M Buy
2,120
+837
+65% +$570K 0.13% 118
2025
Q3
$819K Sell
1,283
-205
-14% -$124K 0.08% 195
2025
Q2
$798K Buy
1,488
+133
+10% +$63.6K 0.08% 180
2025
Q1
$569K Buy
1,355
+114
+9% +$49.5K 0.07% 226
2024
Q4
$513K Buy
1,241
+164
+15% +$71.9K 0.06% 237
2024
Q3
$544K Buy
1,077
+87
+9% +$42.3K 0.07% 225
2024
Q2
$482K Buy
990
+13
+1% +$6.53K 0.06% 209
2024
Q1
$527K Buy
977
+60
+7% +$32.8K 0.07% 199
2023
Q4
$509K Sell
917
-942
-51% -$442K 0.08% 174
2023
Q3
$813K Buy
1,859
+1,207
+185% +$602K 0.14% 72
2023
Q2
$328K Buy
652
+86
+15% +$41.2K 0.06% 148
2023
Q1
$283K Buy
566
+17
+3% +$8.13K 0.06% 128
2022
Q4
$224K Buy
+549
New +$213K 0.06% 147
2022
Q1
Sell
-422
Closed -$278K 119
2021
Q4
$278K Buy
+422
New +$265K 0.08% 73
2021
Q1
Sell
-17
Closed -$9K 376
2020
Q4
$9K Buy
+17
New +$7.61K ﹤0.01% 535

Other funds holding IDXX

Inspire Advisors's IDXX Position: Q1 2026 in Review

Inspire Advisors increased its Idexx Laboratories (IDXX) stake by 13% in Q1 2026, buying an estimated $171K and bringing the position to 2,387 shares worth $1.34M. The position accounts for 0.11% of the portfolio, ranked #147.

Inspire Advisors first reported a position in IDXX in Q4 2020 and has held it in 16 quarters since. The position peaked at $1.43M in Q4 2025. 1,311 funds tracked by Wall St. Rank hold IDXX as of Q1 2026.

  • Inspire Advisors held 2,387 shares of Idexx Laboratories worth $1.34M as of Q1 2026.
  • Inspire Advisors bought 267 Idexx Laboratories shares in Q1 2026, an estimated $171K.
  • Idexx Laboratories made up 0.11% of Inspire Advisors's portfolio in Q1 2026, its #147 holding.
  • Inspire Advisors first reported a position in Idexx Laboratories in Q4 2020 and has held it in 16 quarters since.
  • Inspire Advisors's Idexx Laboratories position peaked at $1.43M in Q4 2025.
  • 1,311 funds tracked by Wall St. Rank held Idexx Laboratories as of Q1 2026.

Based on Inspire Advisors's 13F filing for Q1 2026, filed 15 May 2026.